Pharmacelera raises €6 million to expand in U.S. and build out its high speed, high accura... 18/02/2026 Financing The investment round was led by investment fund manager Heran Partners, with participation from Clave Capital, Inveready... Partners - Parc Científic de Barcelona
Spain-USA business meeting in Boston Boston Estados Unidos Del 13/04/2026 to 14/04/2026 International Financing Call for applications closed.
Adigital, AESEMI and AseBio drive a joint proposal to position Spain at the forefront of d... 25/11/2025 Healthcare Industrial biotechnology Financing The aim of this document is to promote a specific regulatory framework that recognises these technologies as a strategic... AseBio
Adigital, AESEMI and AseBio drive a joint proposal to position Spain at the forefront of d... 25/11/2025 The three national associations have submitted a joint document to the Ministry of Science, Innovation and Universities... AseBio
ORYZON reports financial results and corporate update for quarter ended September 30, 2025 11/11/2025 Healthcare Financing The net result as of September 30, 2025 improved by $1.1M compared to September 2024, following termination of a... Partners - Oryzon Genomics
AseBio participates in the public consultation of the upcoming Biotech Act with proposals ... 07/11/2025 Healthcare Industrial biotechnology International Financing Harmonizing regulation, improving access to funding and talent, advancing biomanufacturing and artificial intelligence... AseBio
Qida raises €37 million to continue improving the quality of life of the senior segment at... 04/11/2025 Financing The investment will enable Qida to boost growth, technological innovation, and the attraction of top talent, with the... Partners - Asabys Partners
GENESIS Biomed participated in the strategic development of AptaTargets, which has license... 30/10/2025 Access to innovation Financing AptaTargets signed in May 2025 a licensing agreement with Merck for the clinical development and global... Partners - GENESIS Biomed
